Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis (Q37731528)

22 August 2017

1 reference

title

Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis (English)

1 reference

22 August 2017

0 references

1 reference

2

Sohita Dhillon

1 reference

22 August 2017

1

Emma D Deeks

1 reference

22 August 2017

publication date

1 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

70

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

733-759

1 reference

The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate

22 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F10481900-000000000-00000

Rebalancing bone turnover in favour of formation with strontium ranelate: implications for bone strength.

21 January 2018

1 reference

12 December 2020

Short-term hemostatic safety of strontium ranelate treatment in elderly women with osteoporosis

1 reference

12 December 2020

Osteoblasts play key roles in the mechanisms of action of strontium ranelate

1 reference

12 December 2020

No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial

1 reference

12 December 2020

The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation

1 reference

12 December 2020

The effects of strontium ranelate in Asian women with postmenopausal osteoporosis

1 reference

12 December 2020

Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis).

1 reference

12 December 2020

Effect of long-term treatment with strontium ranelate on bone strontium content

1 reference

12 December 2020

The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis

1 reference

12 December 2020

Raloxifene use in clinical practice: efficacy and safety

1 reference

12 December 2020

How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy

1 reference

12 December 2020

Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.

1 reference

12 December 2020

Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database

1 reference

12 December 2020

Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover

1 reference

12 December 2020

Strontium ranelate for preventing and treating postmenopausal osteoporosis

1 reference

12 December 2020

Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years.

1 reference

12 December 2020

Induction of a program gene expression during osteoblast differentiation with strontium ranelate

1 reference

12 December 2020

Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity

1 reference

12 December 2020

Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength.

1 reference

12 December 2020

Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis

1 reference

12 December 2020

An analysis of which anti-osteoporosis therapeutic regimen would improve compliance in a population of elderly adults

1 reference

12 December 2020

Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone.

1 reference

12 December 2020

Mechanisms of action and therapeutic potential of strontium in bone

1 reference

12 December 2020

Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures

1 reference

12 December 2020

Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective.

1 reference

12 December 2020

Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial

1 reference

12 December 2020

Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants

1 reference

12 December 2020

In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor

1 reference

12 December 2020

Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy

1 reference

12 December 2020

Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia

1 reference

12 December 2020

In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation

1 reference

12 December 2020

Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate.

1 reference

12 December 2020

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

1 reference

12 December 2020

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

1 reference

12 December 2020

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

1 reference

12 December 2020

An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting: based on the results of the SOTI and TROPOS trials.

1 reference

12 December 2020

S12911-2 reduces bone loss induced by short-term immobilization in rats

1 reference

12 December 2020

In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization.

1 reference

12 December 2020

Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis

1 reference

12 December 2020

Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older

1 reference

12 December 2020

Patient adherence to osteoporosis medications: problems, consequences and management strategies.

1 reference

12 December 2020

An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats.

1 reference

12 December 2020

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

1 reference

12 December 2020

Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats

1 reference

12 December 2020

Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro

1 reference

12 December 2020

Anabolic Agents for Osteoporosis : What is Their Likely Place in Therapy?

1 reference

12 December 2020

The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro

1 reference

12 December 2020

Calcium sensing receptor-dependent and receptor-independent activation of osteoblast replication and survival by strontium ranelate.

1 reference

12 December 2020

Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women.

1 reference

12 December 2020

Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation

1 reference

12 December 2020

Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis

1 reference

12 December 2020

Management of osteoporosis in the elderly.

1 reference

12 December 2020

Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors

1 reference

12 December 2020

Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate

1 reference

12 December 2020

Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club

1 reference

12 December 2020

Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing

1 reference

12 December 2020

Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats

1 reference

12 December 2020

Zoledronic acid: a review of its use in the treatment of osteoporosis

1 reference

12 December 2020

Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat

1 reference

12 December 2020

S 12911-2 inhibits osteoclastic bone resorption in vitro

1 reference

12 December 2020

Effects of strontium ranelate on spinal osteoarthritis progression.

1 reference

12 December 2020

The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways

1 reference

12 December 2020

Efficacy and safety of 2 g/day of strontium ranelate in Asian women with postmenopausal osteoporosis.

1 reference

12 December 2020

Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age.

1 reference

12 December 2020

The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study

1 reference

12 December 2020

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

1 reference

12 December 2020

Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial

1 reference

12 December 2020

Monitoring strontium ranelate therapy in patients with osteoporosis

1 reference

12 December 2020

Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years

1 reference

12 December 2020

Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions

1 reference

12 December 2020

Strontium ranelate: a new paradigm in the treatment of osteoporosis.

1 reference

12 December 2020

Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate

1 reference

12 December 2020

Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis

1 reference

12 December 2020

Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women

1 reference

12 December 2020

Adherence to osteoporosis treatments: room for improvement

1 reference

12 December 2020

Update on the treatment of post-menopausal osteoporosis

1 reference

12 December 2020

Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms

1 reference

12 December 2020

Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response

1 reference

12 December 2020

Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years

1 reference

12 December 2020

Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide

1 reference

12 December 2020

Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice

1 reference

12 December 2020

10.2165/10481900-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

22 August 2017

1012037004

0 references

1 reference